Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000708275 | SCV000837385 | pathogenic | Rhabdoid tumor predisposition syndrome 2 | 2019-11-01 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in SMARCA4 are known to be pathogenic (PMID: 24658001, 24658002). This variant has not been reported in the literature in individuals with SMARCA4-related conditions. This variant is an out-of-frame deletion of the genomic region encompassing exons 17-25 of the SMARCA4 gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product. |